Stay updated on Nivolumab Combo in Breast Cancer Pre-Op Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Breast Cancer Pre-Op Clinical Trial page.

Latest updates to the Nivolumab Combo in Breast Cancer Pre-Op Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check23 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check59 days agoChange DetectedThe web page has been updated to reflect new details about a clinical trial for breast cancer, including the opening of separate cohorts for LumB and TNBC tumors, and the involvement of collaborators such as Bristol-Myers Squibb. Additionally, the revision number has been updated to v2.15.0.SummaryDifference30%
Stay in the know with updates to Nivolumab Combo in Breast Cancer Pre-Op Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Breast Cancer Pre-Op Clinical Trial page.